Learn More
Invitrogen™ TRBC1 Chimeric Recombinant Mouse Monoclonal Antibody (JOVI.1)
Description
Recombinant human-mouse chimeric monoclonal antibodies are produced using in vitro expression systems. Recombinant antibodies are produced using specific genes that code for the desired antibodies. These genes are cloned into an expression vector and expressed in vitro. The advantages of recombinant antibodies include better specificity and lot-to-lot consistency. It is recommended that the antibody be carefully titrated for optimal performance in the assay of interest.
Specifications
Specifications
| Antigen | TRBC1 Chimeric |
| Applications | Flow Cytometry |
| Classification | Recombinant Monoclonal |
| Clone | JOVI.1 |
| Concentration | 0.5 mg/mL |
| Conjugate | Unconjugated |
| Formulation | PBS with 0.09% sodium azide; pH 7.4 |
| Gene | TRBC1 |
| Gene Accession No. | P01850 |
| Gene Alias | BV05S1J2.2; T cell receptor beta constant 1; TCRB; TCRBC1; TRBC1 |
| Show More |
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.